SPARK THERAPEUTICS, INC. Operating Cash Flow
SPARK THERAPEUTICS, INC. reported Operating Cash Flow of -$100.45 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2019-11-07
- SPARK THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2019-09-30 was -$18.38M.
- SPARK THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2019-06-30 was -$49.97M.
- SPARK THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2019-03-31 was -$32.10M, a 160.56% decline year-over-year.
- SPARK THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2018-12-31 was -$42.53M.
- SPARK THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2018 was -$70.56M.
- SPARK THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2017 was -$154.54M.
- SPARK THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2016 was -$80.44M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2019-09-30 | -$18.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$68.35M derived: sum of 2 quarters · filed 2019-11-07 | -$100.45M 10-Q · filed 2019-11-07 | -$142.97M derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | -$49.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$82.07M 10-Q · filed 2019-08-08 | -$124.60M derived: sum of 3 quarters · filed 2019-08-08 | -$156.87M derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-03-31 | -$32.10M 10-Q · filed 2019-05-10 | -$74.63M derived: sum of 2 quarters · filed 2019-05-10 | -$106.90M derived: sum of 3 quarters · filed 2019-11-07 | -$155.66M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-12-31 | -$42.53M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$74.80M derived: sum of 2 quarters · filed 2019-11-07 | -$123.56M derived: sum of 3 quarters · filed 2019-11-07 | -$70.56M 10-K · filed 2019-02-28 |
| 2018-09-30 | -$32.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$81.04M derived: sum of 2 quarters · filed 2019-11-07 | -$28.04M 10-Q · filed 2019-11-07 | -$54.78M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | -$48.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $4.24M 10-Q · filed 2019-08-08 | -$22.51M derived: sum of 3 quarters · filed 2019-08-08 | |
| 2018-03-31 | $53.00M 10-Q · filed 2019-05-10 | $26.26M derived: sum of 2 quarters · filed 2019-05-10 | ||
| 2017-12-31 | -$26.74M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$154.54M 10-K · filed 2019-02-28 | ||
| 2017-09-30 | -$127.79M 10-Q · filed 2018-11-06 | |||
| 2016-12-31 | -$80.44M 10-K · filed 2019-02-28 |